Envue Medical Inc (FEED)

$2.78 -0.09 (-3.14%)
Market Cap 3.03M
Revenue (ttm) 2.56M
Net Income (ttm) -3.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -144.92%
Debt to Equity Ratio 0.02
Volume 13,300
Avg Vol 30,150
Day's Range N/A - N/A
Shares Out 1.09M
Stochastic %K 1%
Beta 2.05
Analysts Strong Buy
Price Target $3.50
topstockalerts
topstockalerts Dec. 16 at 3:56 AM
Top Gainers $FEED $AMCI $RADX $ARTV $MASK.X
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 9:39 PM
Top Gainers $FEED $AMCI $RADX $ARTV $MASK.X
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 8:10 PM
Top Gainers $FEED $AMCI $RADX $ARTV $MASK
0 · Reply
RBLUCKY
RBLUCKY Dec. 15 at 8:06 PM
$FEED LOL  the new chairman of the board Johnson is one of the biggest thief’s in penny, stock land! The last company he worked with in Enveric biosciences ENVB is down 99.9% the biggest fucking liar on the planet.
1 · Reply
BioTuesdays
BioTuesdays Dec. 15 at 6:49 PM
$FEED announced the appointment of David Johnson as chairman of the board https://biotuesdays.com/2025/12/15/envue-appoints-david-johnson-as-chairman/
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 6:07 PM
Top Gainers $FEED $AMCI $RADX $ARTV $CLYM
0 · Reply
frontiere
frontiere Dec. 15 at 4:52 PM
so $NAOV NanoVibronix became $FEED ENVue Medical (Envizion) ref=$3.85 now — NO pstn — are they related to COCH Envoy Medical ex-SPAC ??? )) Doesn’t seem so after a quick search, but names of 2 micro/nanocaps in the same sector so similar))) I see NAOV acquired FEED on 2025-02-14 https://lifesciencereport.com/news/nasdaq/feed/nanovibronix-inc-announces-acquisition-of-envue-medical-holdings-corp Anyway, shs outs=1m w cash=$7.0m as of 2025-09-30 and burn per Qtr=$2.2m — will definitely raise in the short term. 👍Maybe a setup soon for a long. 🚩 Israel + Texas trading sardine. Date, not marry. 🚩 no running clinical trials (no PR potential from this) https://www.clinicaltrials.gov/search?term=Envizion%20OR%20ENVUE%20OR%20Nanovibronix Content-rich website https://envuemed.com/news-and-events/
1 · Reply
topstockalerts
topstockalerts Dec. 15 at 3:19 PM
Top Gainers $FEED $RADX $MASK $AMCI $QIPT
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 1:55 PM
Pre Market Top Gainers $FEED $RADX $MASK $OCG $QIPT
0 · Reply
sweet_Journey
sweet_Journey Dec. 15 at 1:41 PM
$FEED $RADX $MASK.X $MIST $OCG 👇🏼 🔥
1 · Reply
Latest News on FEED
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

Dec 18, 2025, 12:30 PM EST - 7 days ago

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

Dec 15, 2025, 9:00 AM EST - 10 days ago

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'

Dec 12, 2025, 8:00 AM EST - 13 days ago

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'

NanoVibronix Issues Letter to Shareholders

Nov 19, 2025, 8:00 AM EST - 5 weeks ago

NanoVibronix Issues Letter to Shareholders

NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

Sep 18, 2025, 8:00 AM EDT - 3 months ago

NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 16, 2025, 3:57 PM EDT - 3 months ago

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio

Sep 15, 2025, 8:00 AM EDT - 3 months ago

NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio

NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

Sep 4, 2025, 8:00 AM EDT - 4 months ago

NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

NanoVibronix Announces Reverse Stock Split

Aug 8, 2025, 9:00 AM EDT - 4 months ago

NanoVibronix Announces Reverse Stock Split

NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock

Jul 18, 2025, 9:00 AM EDT - 5 months ago

NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock

NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

Jun 26, 2025, 8:00 AM EDT - 6 months ago

NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement

Jun 24, 2025, 8:00 AM EDT - 6 months ago

NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

Jun 11, 2025, 8:00 AM EDT - 7 months ago

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

NanoVibronix Announces CEO Transition

Jun 4, 2025, 8:38 AM EDT - 7 months ago

NanoVibronix Announces CEO Transition

NanoVibronix Responds to False Post

May 28, 2025, 4:22 PM EDT - 7 months ago

NanoVibronix Responds to False Post

Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures

May 28, 2025, 8:00 AM EDT - 7 months ago

Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures

NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants

May 16, 2025, 4:30 PM EDT - 7 months ago

NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants

NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants

May 15, 2025, 9:00 AM EDT - 8 months ago

NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants

NanoVibronix Announces Results from UroShield™ Case Series

May 12, 2025, 8:50 AM EDT - 8 months ago

NanoVibronix Announces Results from UroShield™ Case Series

NanoVibronix Regains Nasdaq Compliance

Apr 11, 2025, 8:00 AM EDT - 9 months ago

NanoVibronix Regains Nasdaq Compliance

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Apr 1, 2025, 8:00 AM EDT - 9 months ago

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

Mar 14, 2025, 8:00 AM EDT - 10 months ago

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

Feb 14, 2025, 9:43 AM EST - 11 months ago

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

Jan 7, 2025, 8:00 AM EST - 1 year ago

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

Jan 6, 2025, 8:00 AM EST - 1 year ago

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

Dec 11, 2024, 8:00 AM EST - 1 year ago

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

NanoVibronix Provides Business Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

NanoVibronix Provides Business Update

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

Oct 9, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

NanoVibronix Signs Letter of Intent with Potential New Distributor

Sep 23, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Signs Letter of Intent with Potential New Distributor

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

Aug 21, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

May 22, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

NanoVibronix Issues Letter to Stockholders

May 16, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Issues Letter to Stockholders

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

May 14, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

May 1, 2024, 8:00 AM EDT - 1 year ago

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

Apr 24, 2024, 1:00 PM EDT - 1 year ago

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

Mar 28, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

NanoVibronix Featured in Your Bladder Health Magazine

Dec 6, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Featured in Your Bladder Health Magazine

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

Dec 4, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

Nov 28, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1

Nov 7, 2023, 8:30 AM EST - 2 years ago

NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1

NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Sep 27, 2023, 8:00 AM EDT - 2 years ago

NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

Sep 6, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Aug 30, 2023, 2:29 PM EDT - 2 years ago

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

NanoVibronix Cites Positive Results from Independent Testing of UroShield

Aug 30, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Cites Positive Results from Independent Testing of UroShield

NanoVibronix Responds to CMS' Determination for PainShield

Aug 29, 2023, 4:05 PM EDT - 2 years ago

NanoVibronix Responds to CMS' Determination for PainShield

NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Aug 28, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus

Aug 23, 2023, 8:45 AM EDT - 2 years ago

NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus

NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard

Jun 14, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard

NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)

Mar 28, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)

NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra

Mar 21, 2023, 8:30 AM EDT - 3 years ago

NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra

topstockalerts
topstockalerts Dec. 16 at 3:56 AM
Top Gainers $FEED $AMCI $RADX $ARTV $MASK.X
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 9:39 PM
Top Gainers $FEED $AMCI $RADX $ARTV $MASK.X
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 8:10 PM
Top Gainers $FEED $AMCI $RADX $ARTV $MASK
0 · Reply
RBLUCKY
RBLUCKY Dec. 15 at 8:06 PM
$FEED LOL  the new chairman of the board Johnson is one of the biggest thief’s in penny, stock land! The last company he worked with in Enveric biosciences ENVB is down 99.9% the biggest fucking liar on the planet.
1 · Reply
BioTuesdays
BioTuesdays Dec. 15 at 6:49 PM
$FEED announced the appointment of David Johnson as chairman of the board https://biotuesdays.com/2025/12/15/envue-appoints-david-johnson-as-chairman/
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 6:07 PM
Top Gainers $FEED $AMCI $RADX $ARTV $CLYM
0 · Reply
frontiere
frontiere Dec. 15 at 4:52 PM
so $NAOV NanoVibronix became $FEED ENVue Medical (Envizion) ref=$3.85 now — NO pstn — are they related to COCH Envoy Medical ex-SPAC ??? )) Doesn’t seem so after a quick search, but names of 2 micro/nanocaps in the same sector so similar))) I see NAOV acquired FEED on 2025-02-14 https://lifesciencereport.com/news/nasdaq/feed/nanovibronix-inc-announces-acquisition-of-envue-medical-holdings-corp Anyway, shs outs=1m w cash=$7.0m as of 2025-09-30 and burn per Qtr=$2.2m — will definitely raise in the short term. 👍Maybe a setup soon for a long. 🚩 Israel + Texas trading sardine. Date, not marry. 🚩 no running clinical trials (no PR potential from this) https://www.clinicaltrials.gov/search?term=Envizion%20OR%20ENVUE%20OR%20Nanovibronix Content-rich website https://envuemed.com/news-and-events/
1 · Reply
topstockalerts
topstockalerts Dec. 15 at 3:19 PM
Top Gainers $FEED $RADX $MASK $AMCI $QIPT
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 1:55 PM
Pre Market Top Gainers $FEED $RADX $MASK $OCG $QIPT
0 · Reply
sweet_Journey
sweet_Journey Dec. 15 at 1:41 PM
$FEED $RADX $MASK.X $MIST $OCG 👇🏼 🔥
1 · Reply
sweet_Journey
sweet_Journey Dec. 15 at 1:19 PM
$FEED $RADX $MASK.X $MIST $OCG 👇🏼💎
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 1:00 PM
Pre Market Top Gainers $FEED $RADX $MASK.X $MIST $OCG
0 · Reply
frankyboyz
frankyboyz Dec. 15 at 7:52 AM
Support and retweet: #frankysWL The one and only Franky’s Watchlist Dec. 15, 2025 Edition Your daily dose of high-potential setups & sharp trade ideas to stay ahead. Afterhours Movers – Let’s Dive In: ━━━━━━━━━━━━━━━━━━━━━ $AMCI $ARBK $FEED $WOK https://x.com/frankyboyz/status/2000473952678793393 Franky
0 · Reply
BULLNATION_
BULLNATION_ Dec. 12 at 4:53 PM
$FEED @Stocktwits this ticker belongs to Envue Med Inc now it was called $NAOV before
1 · Reply
BULLNATION_
BULLNATION_ Dec. 12 at 4:49 PM
$NIVF we have not being very active lately to none of our stocks as we are working massively on our developments. still holding: $WLDS now entering the health sector with their EMG patented tech, received $750K $FEED (before $NAOV ) FDA C meeting outcome to join FrontRunner
0 · Reply
sn0wball
sn0wball Dec. 12 at 3:33 PM
$FEED Recent News on NanoVibronix As of December 12, 2025, NanoVibronix has officially rebranded itself as ENvue Medical, Inc.. This change comes alongside a new ticker symbol, FEED, which they will use for trading on the Nasdaq. The rebranding aims to align with the company's renewed strategic focus on their ENvue® feeding-tube placement system.
0 · Reply
stockanalysis_
stockanalysis_ Dec. 12 at 3:17 PM
Gainers Today: $FEED $RYM $YCBD $ZDGE $NCI Bookmark this page: https://stockanalysis.com/markets/gainers/?ref=saveontrading
0 · Reply
sn0wball
sn0wball Dec. 12 at 3:01 PM
$FEED
0 · Reply
FROGGER111
FROGGER111 Apr. 14 at 4:05 AM
$BSFC is $FEED for $HERO About Eagle Rising Eagle Rising is a Service-Disabled Veteran-Owned Small Business specializing in high-quality food solutions for military personnel, communities in crisis, and disaster relief efforts. With a commitment to feeding heroes and making products in the USA , Eagle Rising is proud to support those who serve and protect around the globe. Learn more at (https://eaglerisingfs.com/).
0 · Reply
fla
fla May. 29 at 8:31 AM
$FEED [15s. delayed]: Issued Press Release on May 29, 04:30:00: [Latest] Global Orthodontics Market Size/Share Worth USD 7,637.8 Million b https://s.flashalert.me/WYpnF2
0 · Reply
fla
fla May. 9 at 5:03 PM
$FEED [15s. delayed]: Issued Press Release on May 09, 13:00:00: [Latest] U.S. Weight Loss Market Size/Share Worth USD 305.30 Billion by 20 https://s.flashalert.me/ET9P31
0 · Reply
fla
fla Apr. 26 at 8:31 PM
$FEED [15s. delayed]: Issued Press Release on April 26, 16:30:00: [Latest Report] US Animal Health Market Size/Share Worth USD 11.3 Billio https://s.flashalert.me/p4rT0D
0 · Reply